Press Release in connection with the Audited Financial Results of the Company for the Quarter and Year Ended 31st March, 2026
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 14 May 2026, 11:51 AM IST · BSE ID: 663c8726-6e68-4674-82e7-4fcd54471d62
View Original BSE Filing (PDF)
💡
In Simple Terms
Balaji Amines announced its financial results, showing higher quarterly and annual profits, and detailed ongoing expansion projects.
🤖 AI Summary
- Balaji Amines Q4FY26 consolidated total income stood at ₹ 403 Crore, with net profit at ₹ 65 Crore.
- FY26 consolidated total income reached ₹ 1,454 Crore, and consolidated PAT was ₹ 169 Crore.
- New projects include a DME plant and N-Methyl Morpholine (NMM) expansion, expected Q1FY27 and FY27 respectively.
- Balaji Speciality Chemicals Limited received Mega Project status for a ₹ 750 Crores expansion.
- A brownfield project at Unit-I and greenfield project at Unit-II are under execution, planned for FY27 commissioning.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Total Income Q4FY26
₹ 403 Crore
11.63%
Consolidated EBITDA Q4FY26
₹ 102 Crore
50.00%
Consolidated PAT Q4FY26
₹ 65 Crore
62.50%
Consolidated Total Income FY26
₹ 1,454 Crore
1.68%
Consolidated EBITDA FY26
₹ 294 Crore
10.94%
Consolidated PAT FY26
₹ 169 Crore
6.29%
Diluted EPS Q4FY26
₹ 19.99 per equity share
🏢 How This Affects the Company
The commissioning of new plants for DME, N-Methyl Morpholine, and Acetonitrile will expand the company's product portfolio and potentially strengthen its position in the aerosol, specialty chemicals, and pharma sectors. The expansion in Balaji Speciality Chemicals Limited with a ₹ 750 Crores investment aims to broaden the range of products including Hydrogen Cyanide and EDTA derivatives.
Consolidated Q4FY26 PAT increased to ₹ 65 Crore from ₹ 40 Crore in Q4FY25, and FY26 consolidated PAT increased to ₹ 169 Crore from ₹ 159 Crore in FY25. The new projects are funded through internal accruals, which indicates efficient cash flow management and avoids additional debt on the standalone balance sheet.
The planned commissioning of new plants and execution of brownfield and greenfield projects will significantly increase manufacturing capacity and product diversity. The company maintained stable plant operations despite a brief external disruption in March 2026, supported by prudent inventory planning.
The company’s declaration of being a zero-debt company on a standalone basis reduces financial leverage risk. However, the successful commissioning and ramp-up of multiple new projects introduce execution risks related to timelines and market acceptance.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders based on this financial results and press release filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the increase in consolidated PAT to ₹ 169 Crore for FY26 and the declared expansion plans. The Diluted EPS for Q4FY26 stood at ₹ 19.99 per equity share.
🔍
Management Signal
Management is signaling a focus on expanding production capacity and diversifying the product portfolio through internal accruals, reinforcing a commitment to growth and financial prudence.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q1FY27 results — monitor revenue and profit figures
DME Plant commissioning — watch for official announcement
Acetonitrile plant commissioning — track for Q2FY27 update
LOW RISK
Strong financial performance and project funding via internal accruals reduce immediate financial risks.
💡 Investor Takeaway
Balaji Amines reported a consolidated Q4FY26 Net Profit of ₹ 65 Crore, a 62.50% increase from ₹ 40 Crore in Q4FY25. FY26 consolidated total income was ₹ 1,454 Crore, up from ₹ 1,430 Crore in FY25, confirming sustained operational performance and strategic expansion plans.
⚖️ Strengths & Concerns
✅ Positives
- Consolidated Q4FY26 Net Profit increased to ₹ 65 Crore from ₹ 40 Crore in Q4FY25, representing a 62.50% YoY growth.
- FY26 Consolidated Total Income grew to ₹ 1,454 Crore from ₹ 1,430 Crore in FY25, alongside an increase in consolidated EBITDA to ₹ 294 Crore from ₹ 265 Crore.
⚠️ Concerns
- Consolidated total income only increased by 1.68% from ₹ 1,430 Crore in FY25 to ₹ 1,454 Crore in FY26, indicating modest full-year top-line growth.
- While Q4FY26 revenue saw an approximate 12% increase over Q3FY26, the specific reason cited as commodity prices suggests potential volatility in revenue growth not solely driven by volume.
📅 Company Track Record
Balaji Amines previously reported FY26 profit of Rs 16,552.83 Lakhs and recommended a dividend of Rs 11/- in a May 13, 2026 filing. The current press release provides additional consolidated figures and details on expansion projects.
Based on publicly available historical data. For context only.